T&R Biofab Co., Ltd. announced a private placement of 314,960 common shares at an issue price of KRW 6,350 each for gross proceeds of KRW 1,999,996,000 on December 14, 2023. The common shares have a face value of KRW 500 per share. The transaction will include participation from returning investor, Korea Investment Bio-Global Fund, a fund managed by Korea Investment Partners Co.

Ltd., for KRW 999,998,000 and new investor, DreamCIS, Inc. for KRW 999,998,000. The transaction has been approved by the board of directors of the company. The capital will be raised through third party allocation method.

The payment date for the transaction is December 22, 2023.